H5 혈청형 조류인플루엔자의 감염을 예방하기 위한저병원성 조류인플루엔자 바이러스 백신주
    11.
    发明公开
    H5 혈청형 조류인플루엔자의 감염을 예방하기 위한저병원성 조류인플루엔자 바이러스 백신주 有权
    低致病性AVIAN流感病毒疫苗,用于预防H5亚型禽流感病毒感染

    公开(公告)号:KR1020060132155A

    公开(公告)日:2006-12-21

    申请号:KR1020050052325

    申请日:2005-06-17

    CPC classification number: A61K39/145 A61K38/02 Y10S514/888

    Abstract: A low pathogenic avian influenza viral vaccine for preventing H5 subtype avian influenza viral infection is provided to enhance safety and medicinal efficacy of use, and prevent the infection of H5N1 type high pathogenic avian influenza virus safely. The method for preparing the low pathogenic avian influenza viral vaccine for preventing H5 subtype avian influenza viral infection comprises the steps of: (1) culturing a A/wild bird feces/Korea/CSM-2/02(H5N3) strain in a specific pathogen free egg(SPF egg) for 72 hours and collecting allantoic fluid; (2) measuring the titrate of the virus collected in step(1) through hemagglutination inhibition test; (3) concentrating the virus 10 times by centrifuging the virus at 18,000 rpm for 3 hours; (4) attenuating the virus by treating the concentrated virus with 0.1% formalin at 20 deg.C for 12 hours; and (5) mixing the attenuated virus solution with oil adjuvant ISA70 in a weight ratio of 3:7, wherein the low pathogenic avian influenza viral vaccine contains at least one protein encoded by the gene of SEQ ID NO:2 to SEQ ID NO:9.

    Abstract translation: 提供用于预防H5亚型禽流感病毒感染的低致病性禽流感病毒疫苗,以提高使用的安全性和药用效力,并安全防止H5N1型高致病性禽流感病毒感染。 制备用于预防H5亚型禽流感病毒感染的低致病性禽流感病毒疫苗的方法包括以下步骤:(1)在特定病原体中培养A /野鸟粪/韩国/ CSM-2/02(H5N3)菌株 免费鸡蛋(SPF蛋)72小时并收集尿囊液; (2)通过血细胞凝集抑制试验测定步骤(1)中收集的病毒的滴度; (3)通过以18,000rpm将病毒离心3小时来浓缩病毒10次; (4)通过用0.1%福尔马林在20℃处理浓缩的病毒12小时来减毒病毒; 和(5)将减毒病毒溶液与油佐剂ISA70以3:7的重量比混合,其中低致病性禽流感病毒疫苗含有由SEQ ID NO:2至SEQ ID NO:2的基因编码的至少一种蛋白质。 9。

    면역원성이 향상된 인플루엔자 바이러스의 HA2 공통 에피톱의 제조 방법
    17.
    发明公开
    면역원성이 향상된 인플루엔자 바이러스의 HA2 공통 에피톱의 제조 방법 有权
    制备具有改善免疫原性的流感病毒HA2通用抗原决定基的方法

    公开(公告)号:KR1020140010583A

    公开(公告)日:2014-01-27

    申请号:KR1020120076917

    申请日:2012-07-13

    Abstract: Provided are: a method for improving immunogenicity of a HA2 common epitope of influenza virus by replacing asparagine, which is the 154th amino acid, and serine (S) or threonine (T), which is the 156the amino acid, with other amino acid such that N-glycan generation does not occur at asparagine (N), which is the 154th amino acid, of a HA2 fragment derived from a HA amino acid of avian influenza virus; and a recombinant virus with improved immunogenicity through the method. The technic for improving immunogenicity of a HA2 common epitope and the HA2 common epitope high immunogenicity virus of the present invention can be effectively used in developing a vaccine strain for preventing influenza and effectively used as a vaccine strain.

    Abstract translation: 提供:通过将作为第154位氨基酸的天冬酰胺和作为氨基酸的156位的丝氨酸(S)或苏氨酸(T)与其它氨基酸这样的氨基酸取代来改善流感病毒的HA2常见表位的免疫原性的方法 来自禽流感病毒的HA氨基酸的HA2片段的第155位氨基酸的天冬酰胺(N)不发生N-聚糖生成; 和通过该方法具有改善的免疫原性的重组病毒。 用于提高本发明的HA2常见表位和HA2常见表位高免疫原性病毒的免疫原性的技术可以有效地用于开发用于预防流行性感冒并有效用作疫苗株的疫苗株。

    발육계란 고증식성, 무병원성 인플루엔자 바이러스 제작용 재조합 발현 벡터
    18.
    发明公开
    발육계란 고증식성, 무병원성 인플루엔자 바이러스 제작용 재조합 발현 벡터 有权
    用于制备高产和流行性流感病毒的重组表达载体及其用途

    公开(公告)号:KR1020140010582A

    公开(公告)日:2014-01-27

    申请号:KR1020120076916

    申请日:2012-07-13

    Abstract: The present invention relates to: a composition for high productiveness of an embryonated egg of H1N1 family avian influenza and non-pathogenicity of a mouse including, as a active ingredient, a polynucleotide encoding a PB2 protein of a low pathogenic avian influenza virus; a recombinant expression vector including the polynucleotide; an attenuated recombinant virus transformed into the expression vector; and a vaccine composition including the recombinant expression vector. The recombinant expression vector of the present invention enhances chicken embryo productivity of a vaccine strain for preventing influenza, and thereby, having advantages of being capable of being effectively used in enhancing efficacy and productivity of killed vaccines, and additionally, has no pathogenicity for mice and has immunogenicity, and thereby having advantages of being capable of being effectively used as live vaccines. [Reference numerals] (AA) Inserting into the inside of pHW2000-BsmBI

    Abstract translation: 本发明涉及一种用于H1N1家禽禽流感的胚胎卵和非致病性的高生产力的组合物,其包含作为活性成分的编码低致病性禽流感病毒的PB2蛋白的多核苷酸; 包含该多核苷酸的重组表达载体; 减毒的重组病毒转化成表达载体; 以及包含重组表达载体的疫苗组合物。 本发明的重组表达载体增强用于预防流感的疫苗株的鸡胚生产力,从而具有能够有效地用于提高杀死疫苗的功效和生产力的优点,此外,对小鼠没有致病性, 具有免疫原性,因此具有能够有效地用作活疫苗的优点。 (标号)(AA)插入pHW2000-BsmBI的内部

    돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원
    19.
    发明授权
    돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 有权
    抗高血压高血压治疗日本血吸虫病毒

    公开(公告)号:KR101144993B1

    公开(公告)日:2012-06-27

    申请号:KR1020090054422

    申请日:2009-06-18

    Abstract: PURPOSE: An antigen for hemoglutination for swine Japanese encephalitis virus is provided to reduce pollution caused by acetone extraction. CONSTITUTION: A method for preparing antigen for hemoglutination of high concentration for swine Japanese encephalitis virus comprises: a step of inoculating swine Japanese encephalitis virus to a tissue culture cells and planting; a step of freezing culture liquid; a step of thawing the culture liquid and repeating freezing and thawing once; a step of collecting cultured swine Japanese encephalitis virus; a step of inactivating swine Japanese encephalitis virus; a step of concentrating swine Japanese encephalitis virus; and a step of precipitating swine Japanese encephalitis virus by centrifugation.

Patent Agency Ranking